Table 1 Characteristics of systematic reviews and meta-analyses
First author (year) | Initial language | Number of RCTs (total participants) | Duration of illness | Period of treatment | Intervention | Comparison | Outcomes | Assessment of methodological quality | Adverse event | Subgroup analysis | Sensitivity analysis |
|---|---|---|---|---|---|---|---|---|---|---|---|
Zheng (2011) [6] | English | 7 (230) | Acute | 10–28 (d) | SA + WCM | WCM | ①| Random/blind | Yes | No | No |
Huang (2021) [7] | English | 12 (1,043) | Acute to chronic | 14–180 (d) | SA + WCM + RH | WCM + RH | ② | Cochrane | Yes | No | Yes |
Young (2018) [8] | English | 21 (2,231) | Acute to chronic | 10–60 (t) | SA SA + WCM SA+BA | BA WCM BA | ①②③④ | Modified Jadad/Cochrane | Yes | No | Yes |
Zhou (2013) [9] | English | 13 (1,395) | Acute to chronic | 10–60 (t) | SA + WCM SA | WCM BA | ①②③④ | Random/blind | Yes | No | No |
Lee (2013) [10] | English | 21 (2,172) | Acute to chronic | 10–60 (t) | SA SA SA + WCM SA + RH | WCM RH WCM RH | ①②③④⑤ | Cochrane | Yes | Yes | Yes |
Wang (2012) [11] | English | 8 (538) | Acute | 10–60 (d) | SA+ WCM | WCM | ①④ | Cochrane | Yes | No | No |
Wang (2015) [12] | Chinese | 27 (2,741) | Acute to chronic | 10–60 (d) | SA SA + HM SA + WCM SA | HM HM WCM BA | ①④ | Cochrane | NR | Yes | Yes |